SSY Group Limited announced that the Group has obtained the approvals for drug production and registration for Magnesium Sulfate Injection (20ml: 10g, 10ml: 5g and 2ml: 1g) and Vortioxetine Hydrobromide Tablets (10mg) from the National Medical Products Administration of China, being under type 3 chemical drug and type 4 chemical drug respectively, and regarded as passing the consistency evaluation. As an anticonvulsant drug, Magnesium Sulfate Injection is a mainly used in pregnancy-induced hyper-tension for the treatment of pre-eclampsia and eclampsia by reducing blood pressure. Vortioxetine Hydrobromide Tablets is mainly used for the treatment of depression in adults.